InvoCare is under Algo Engine buy conditions.
In mid-April IVC announced up to $250m equity raising
at $10.40/share.
You're not a member! Trial today
April revenue was down 13% and we’re seeing costs higher than
anticipated. Improvement in trading conditions should occur as the partial easing of restrictions take place.
We assume 2020 earnings will be down 10% and see a recovery into 2021 & 2022.
We’ll revisit IVC if it trades back below $10.00
